Company intelligence / Profile preview

Colorcon

Harleysville, Pennsylvania, United Statescolorcon.com ↗

Ownership: Private
Employees: ~2100
Development stage: Commercial

Overview

Colorcon does not conduct clinical trials or have clinical results as it supplies enabling technologies—such as film coatings, modified release polymers, specialty excipients, and functional packaging—to pharmaceutical manufacturers globally. Its products support the development and commercialization of thousands of marketed drugs.

Recent innovations include titanium dioxide-free high-opacity PVA-based tablet coatings and the consolidation of its controlled-release portfolio under the Corelease™ brand.

Modalities: Small moleculeDevicePolymer-drug conjugate therapyBiologic
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Colorcon.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Colorcon.

Explore the full profile